CO6361855A2 - Derivados de 7-hidroxi-benzoimidazol-4-il-,etanona e inhibidores de cinasa que enlaza pdz que contienen los mismos - Google Patents
Derivados de 7-hidroxi-benzoimidazol-4-il-,etanona e inhibidores de cinasa que enlaza pdz que contienen los mismosInfo
- Publication number
- CO6361855A2 CO6361855A2 CO11060496A CO11060496A CO6361855A2 CO 6361855 A2 CO6361855 A2 CO 6361855A2 CO 11060496 A CO11060496 A CO 11060496A CO 11060496 A CO11060496 A CO 11060496A CO 6361855 A2 CO6361855 A2 CO 6361855A2
- Authority
- CO
- Colombia
- Prior art keywords
- benzoimidazol
- same
- derivatives
- etanona
- hidroxi
- Prior art date
Links
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- GGRAFBSODPLTOT-UHFFFAOYSA-N 7-hydroxy-1h-benzimidazole-4-carbaldehyde Chemical class OC1=CC=C(C=O)C2=C1N=CN2 GGRAFBSODPLTOT-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10980108P | 2008-10-30 | 2008-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6361855A2 true CO6361855A2 (es) | 2012-01-20 |
Family
ID=42129188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO11060496A CO6361855A2 (es) | 2008-10-30 | 2011-05-17 | Derivados de 7-hidroxi-benzoimidazol-4-il-,etanona e inhibidores de cinasa que enlaza pdz que contienen los mismos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110263566A1 (https=) |
| EP (1) | EP2364087A4 (https=) |
| JP (1) | JP2012507525A (https=) |
| KR (1) | KR20110079847A (https=) |
| CN (1) | CN102271514A (https=) |
| AU (1) | AU2009310310A1 (https=) |
| BR (1) | BRPI0919977A2 (https=) |
| CA (1) | CA2741988A1 (https=) |
| CO (1) | CO6361855A2 (https=) |
| IL (1) | IL212544A0 (https=) |
| MX (1) | MX2011004414A (https=) |
| RU (1) | RU2011121665A (https=) |
| WO (1) | WO2010051085A1 (https=) |
| ZA (1) | ZA201103964B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008018642A2 (en) * | 2006-08-10 | 2008-02-14 | Oncotherapy Science, Inc. | Genes and polypeptides relating to breast cancers |
| EP2309855A4 (en) * | 2008-07-30 | 2012-06-27 | Oncotherapy Science Inc | BENZIMIDAZOLE DERIVATIVES AND GLYCOGEN SYNTHASE KINASE-3-BETA INHIBITORS CONTAINING THE SAME |
| BRPI0920959A2 (pt) * | 2008-11-20 | 2017-07-11 | Oncotherapy Science Inc | Inibidores de glicogênio sintase quinase-3 beta contendo derivados de 7-hidróxi-benzoimidazol-4-il-metanona |
| CN101619058A (zh) * | 2009-01-08 | 2010-01-06 | 上海交通大学 | 一种苯并咪唑-4-酰胺型衍生物 |
| KR102232744B1 (ko) * | 2012-12-18 | 2021-03-26 | 이도르시아 파마슈티컬스 리미티드 | Ｐ２ｘ７ 수용체 길항제로서의 인돌 카르복사미드 유도체 |
| CN105017221B (zh) * | 2014-04-30 | 2019-05-28 | 中国医学科学院药物研究所 | 苯并咪唑衍生物及其制法和药物组合物与用途 |
| BR112018001688B1 (pt) | 2015-07-30 | 2023-05-02 | Daiichi Sankyo Company, Limited | Uso de um composto |
| JP6009135B1 (ja) * | 2015-07-30 | 2016-10-19 | 第一三共株式会社 | 成人ｔ細胞白血病リンパ腫の治療及び／又は予防剤 |
| WO2019124608A1 (ko) * | 2017-12-22 | 2019-06-27 | 경상대학교병원 | 4'-(p-톨루엔설포닐아미도)-4-하이드록시칼콘을 유효성분으로 함유하는 류마티스 관절염 예방 또는 치료용 약학 조성물 |
| CN109320461B (zh) * | 2018-12-12 | 2020-02-07 | 迪嘉药业集团有限公司 | 一种替米沙坦中间体的制备方法 |
| AU2020256166A1 (en) | 2019-04-02 | 2021-10-14 | Aligos Therapeutics, Inc. | Compounds targeting PRMT5 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6288100B1 (en) * | 1995-06-06 | 2001-09-11 | American Home Products Corporation | Benzimidazole derivatives |
| US20040002524A1 (en) * | 2002-06-24 | 2004-01-01 | Richard Chesworth | Benzimidazole compounds and their use as estrogen agonists/antagonists |
| JP2006515013A (ja) * | 2003-01-23 | 2006-05-18 | クリスタルジェノミクス、インコーポレイテッド | グリコーゲン合成酵素キナーゼ３β活性抑制剤、組成物及びその製造方法 |
-
2009
- 2009-07-30 KR KR1020117011835A patent/KR20110079847A/ko not_active Withdrawn
- 2009-07-30 US US13/126,741 patent/US20110263566A1/en not_active Abandoned
- 2009-07-30 RU RU2011121665/13A patent/RU2011121665A/ru not_active Application Discontinuation
- 2009-07-30 CA CA2741988A patent/CA2741988A1/en not_active Abandoned
- 2009-07-30 AU AU2009310310A patent/AU2009310310A1/en not_active Withdrawn
- 2009-07-30 EP EP09823973A patent/EP2364087A4/en not_active Withdrawn
- 2009-07-30 CN CN2009801533867A patent/CN102271514A/zh not_active Withdrawn
- 2009-07-30 MX MX2011004414A patent/MX2011004414A/es unknown
- 2009-07-30 JP JP2011534550A patent/JP2012507525A/ja not_active Withdrawn
- 2009-07-30 BR BRPI0919977-2A patent/BRPI0919977A2/pt not_active IP Right Cessation
- 2009-07-30 WO PCT/US2009/052228 patent/WO2010051085A1/en not_active Ceased
-
2011
- 2011-04-28 IL IL212544A patent/IL212544A0/en unknown
- 2011-05-17 CO CO11060496A patent/CO6361855A2/es not_active Application Discontinuation
- 2011-05-30 ZA ZA2011/03964A patent/ZA201103964B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2364087A4 (en) | 2012-05-30 |
| CN102271514A (zh) | 2011-12-07 |
| EP2364087A1 (en) | 2011-09-14 |
| BRPI0919977A2 (pt) | 2015-08-25 |
| ZA201103964B (en) | 2012-02-29 |
| MX2011004414A (es) | 2011-06-21 |
| AU2009310310A2 (en) | 2011-10-06 |
| KR20110079847A (ko) | 2011-07-08 |
| IL212544A0 (en) | 2011-06-30 |
| JP2012507525A (ja) | 2012-03-29 |
| WO2010051085A1 (en) | 2010-05-06 |
| RU2011121665A (ru) | 2012-12-10 |
| CA2741988A1 (en) | 2010-05-06 |
| US20110263566A1 (en) | 2011-10-27 |
| AU2009310310A1 (en) | 2010-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6361855A2 (es) | Derivados de 7-hidroxi-benzoimidazol-4-il-,etanona e inhibidores de cinasa que enlaza pdz que contienen los mismos | |
| CU20110207A7 (es) | Aril piridinas como inhibidoras de sintasa de aldosterona | |
| PH12018501807A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseas | |
| SV2011004077A (es) | Derivados aminobutiricos sustituidos como inhibidores de neprilisina | |
| TN2016000017A1 (en) | Piperidinyl indole derivatives and their use as complement factor b inhibitors | |
| UY33075A (es) | Derivados de ciclohexano y usos de los mismos | |
| JO3577B1 (ar) | صيغ صيدلانية تشمل مشتقات 1-(بيتا-d- غلوكوبيرانوسيل) -2-ثينيل ميثيل بنزين كمثبطات sglt | |
| CO6470847A2 (es) | Derivados amino-propiónicos sustituidos como inhibidores de neprilisina | |
| MX2021008356A (es) | Inhibidores de jak2 y alk2 y metodos para su uso. | |
| MX386542B (es) | Derivados de la 2,3-dihidro-isoindol-1-ona, como inhibidores de la btk quinasa y composiciones farmacéuticas que los incluyen. | |
| MX2016006667A (es) | Derivados de pirrolo-pirrolona y su uso como inhibidores. | |
| UA112298C2 (uk) | Бензімідазолові інгібітори респіраторно-синцитіального вірусу | |
| CU20110233A7 (es) | Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas | |
| PH12014501283A1 (en) | 4`-azido, 3``-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication | |
| MX340360B (es) | Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas. | |
| CO6640327A2 (es) | Compuestos de pirazol como inhibidores del receptor sigma | |
| CR11482A (es) | Derivados de 1,2,3-triazol para uso como inhibidores de estearoil-coenzima a desaturasa | |
| MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
| CU20110113A7 (es) | Lactamas como inhibidores beta secretasa | |
| BR112017016817A2 (pt) | derivados heterocíclicos formilados como inibidores de fgfr4 | |
| UY37837A (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 | |
| UY33348A (es) | Compuestos de furopiridina y usos de los mismos | |
| ES2531312T3 (es) | Formulaciones, sales y polimorfos de transnorsertralina y usos de los mismos | |
| UY33745A (es) | Derivados de difenilamina: usos, procedimiento de síntesis y composiciones farmacéuticas | |
| MX2021014194A (es) | Derivados de piridopirimidina y composiciones farmacéuticas, para su uso para prevenir o tratar enfermedades relacionadas con pi3 cinasa, que comprenden los mismos como principio activo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |